The European Journal of Oncology Pharmacy (EJOP), published quarterly, sets out to offer a professional communication platform to European oncology pharmacy practitioners. As the official journal of the European Society of Oncology Pharmacy (ESOP), the scope of EJOP is to satisfy ESOP members’ needs in terms of improvement on professional standard, setting guidelines, further education and sharing practice experience. EJOP offers ESOP members an insight into the differences and commonalities of oncology pharmacy standards and training, as well as the opportunities to learn the unique benefits and advantages from the different oncology pharmacy practitioners.
EJOP carries an editorial focus for providing information on current development in oncology treatment, sharing practice-related experiences as well as offering an educational platform via conference/seminar reports. The editorial content includes papers in the area of scientific, clinical, therapeutic, economic and social aspects. Prominent experts and eminent professionals support EJOP by sharing their original and qualitative knowledge and insight via high quality review papers covering drug breakthroughs, developments in oncology treatment along with practice guidelines and educational topics which fall within the scope of oncology pharmacy practice.
Source URL: https://ppme.i2ct.eu/publications/ejop/about-ejop/scope-and-profile
Copyright ©2024 PPME unless otherwise noted.